Circulating Tumor Cells Market Worth USD 2.28 Billion By 2020: Grand View Research, Inc.

Global circulating tumor cells market is expected to reach USD 2.28 billion by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of cancer has heightened the need for effective and early diagnosis. Circulating tumor cells cater to this heightened need and are therefore, expected to witness a surge in demand during the forecast period. Majority of cancer deaths are due to circulating tumor cells and an early diagnosis of the same is expected to increase survival rates. Targeted therapy in cancer has large untapped opportunities and therefore, entails extensive R&D investments aimed at new product development. However, high procedure costs and lack of commercialized products are expected to impede market growth during the forecast period.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/circulating-tumor-cells-market

For More Information visit - http://www.grandviewresearch.com/